TelyRx Holdings Inc. experienced a notable uptick in its stock price, reflecting investor optimism.
In yesterday's trading session, TelyRx Holdings Inc. (TELY.TO) saw its stock price rise by 7.14%, closing at CA$2.25. This surge comes as the company reports increasing revenues and expands its operations.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$59.83M
52W high
$4.25
52W low
$2.00
1W change
-4.26%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 166.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+166.7% Upside
Current Price
C$2.25
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
81.4%
Annualized
90-Day Vol
97.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.88
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.12 | C$1.60 – C$2.81 |
| 60 trading days | C$2.00 | C$1.34 – C$2.97 |
| 90 trading days | C$1.88 | C$1.16 – C$3.06 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on TelyRx's growth, especially as it continues to expand and report rising revenues.
TelyRx Holdings Inc. stock closed at CA$2.25, up 7.14%
The market cap of TelyRx now stands at CA$55.84 million, indicating growing interest in the company's future.
Bull case
The company recently reported significant revenue growth, jumping to CA$42.9 million for the year ended December 31, 2025, compared to CA$9.5 million in 2024. This strong financial performance could boost investor confidence.
Bear case
Despite the recent surge, TelyRx faces challenges, including a negative profit margin of -19.36%. Investors should be cautious about whether this growth can be sustained.
Recent Performance Highlights
Advertisement
TelyRx's stock performance yesterday marked a significant increase, closing at CA$2.25. This rise is linked to the company's recent financial results, which show impressive revenue growth.
Future Outlook
With TelyRx's recent expansion in Clearwater, Florida, and its increasing revenue, the company is positioning itself for continued growth. Investors should watch for upcoming financial disclosures and market conditions.
Key Financial Metrics
As of the latest reports, TelyRx holds a market cap of CA$55.84 million. Despite a negative profit margin, the company's revenue growth signals potential opportunities for investors in the healthcare sector.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
